Reach Us +44-1202068036
The Risk Of Thrombosis In Patients With Antiphospholipid Syndrome: Influence Of Antiphospholipid Antibody Type And Levels | 19883
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Hematology & Blood Disorders

Ljudmila Stojanovich
ScientificTracks Abstracts: J Blood Disorders Transf
DOI: 10.4172/2155-9864.S1.006
Introduction: Clinical interest in antiphospholipid antibodies (aPL) is due to their relation with arterial and venous thrombosis in the antiphospholipid syndrome (APS). Patients and methods: We analyzed 488 APS patients: 346 patients with primary (PAPS) and 142 with secondary APS (sAPS/ SLE); 81.5% women and 18.5% men; average age 45.03?13.61. aPL analysis included detection of aCL (IgG/IgM), ?2GPI (IgG/ IgM), and LA. The objective was to observe the prevalence and localization of thrombosis, and correlate it to aPL type and level in patients diagnosed with PAPS or sAPS. Results: Thrombosis was diagnosed in 46.5% patients, with higher prevalence in PAPS compared to sAPS patients (51.2% and 38.3%, respectively, p=0.045). There was similar prevalence of arterial thrombosis in both groups (34.6% and 34%, respectively, p=0.932) although venous thrombosis was more frequent in PAPS (25.9% and 8.5%, respectively, p=0.001). Thrombosis was observed in 55.8% patients who had more than one type of antibodies (category I), in 41.9% patients with category IIa, in 46.3% patients with category IIb, and in 44.2% patients with category IIc (p=0.10). There was no statistically significant difference in the prevalence of arterial/venous thrombosis in patients with low/normal, intermediate, and high levels of aCL and anti-β2GPI (IgG, IgM). Older age in APS patients is a risk factor for thrombosis (median age 49.8 and 39.8, respectively, p=0.001). Conclusion: The prevalence of venous thrombosis was higher in the PAPS group. Antibody category and levels of various types of antibodies did not correlate with the prevalence of thrombosis in the Serbian National Cohort Study.
Ljudmila Stojanovich received her PhD in Medicine, with the thesis ?Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus? in 1999. She is the Scientific Director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Research Professor. Her research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings. She is in Editorial Boards (Editorial Boards LUPUS (London), Reviewer in the ?Current Contents? or ?Science Citation Index?. She is a member of number International Project, like of ?the European Forum on Antiphospholipid Antibodies?, ?Multicentre Studies Antiphospholipid Antibodies, and Infections and Autoimmune Diseases?. She was an invited speaker for many lectures in congresses and symposia; organizer and chairman of many workshops, seminars and symposia; member of the Steering Committee of the ?(EULAR) recommendations for vaccination in patients with auto-immune inflammatory rheumatic diseases (AIIRD)?.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version